Algorae Pharmaceuticals Limited
1AI
Ранг среди акций
#30937
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Цена акции
$0.00705285
Рыночная капитализация
$14.30M
Изменение (1 день)
0.00%
Изменение (1 год)
-30.71%
Страна
AU
Торговля Algorae Pharmaceuticals Limited (1AI)
Категория
Healthcare
Рыночная капитализация Algorae Pharmaceuticals Limited(1AI)
Рыночная капитализация: $14.30M
По состоянию на October 2026 рыночная капитализация Algorae Pharmaceuticals Limited составляет $14.30M. Согласно нашим данным, Algorae Pharmaceuticals Limited занимает 30937th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Algorae Pharmaceuticals Limited с 2004 по 2026
1AI по сравнению с пятеркой самых популярных stocks
